# FDA 483 - Takeda Pharmaceutical Company Limited - November 26, 2019

Source: https://www.globalkeysolutions.net/records/483/takeda-pharmaceutical-company-limited/dc0ab72d-608b-4770-b885-4d26b8d7b7cf

> FDA 483 for Takeda Pharmaceutical Company Limited on November 26, 2019. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Takeda Pharmaceutical Company Limited
- Inspection Date: 2019-11-26
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [483 - 2023-11-06](https://www.globalkeysolutions.net/records/483/takeda-pharmaceutical-company-limited/9830bf69-579a-4bc0-bf7c-8ad2b78a6e53)
- [483 - Unknown Date](https://www.globalkeysolutions.net/records/483/takeda-pharmaceutical-company-limited/3ef01a8a-2f75-42a1-9481-a1f129fd051c)
- [EIR - Unknown Date](https://www.globalkeysolutions.net/records/eir/takeda-pharmaceutical-company-limited/46ebada5-5da9-46b3-a24d-e952bbfada0f)

## Related Officers

- [Steven M. Weinman](https://www.globalkeysolutions.net/people/steven-m-weinman/66ffc074-e34a-4b53-a525-0d4a25c6a220)
- [Ileana Barreto-pettit](https://www.globalkeysolutions.net/people/ileana-barreto-pettit/f740db75-07a2-4990-8d4d-45fb16f33531)

Company: https://www.globalkeysolutions.net/companies/takeda-pharmaceutical-company-limited/0f6bd1ca-94a2-41f0-a8dd-1af20069e6cf

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c